Why activist investors are going to have a busy year

CARL ICAHN owns 1.4% of Illumina, a genomics giant with a market value of $34bn. Mr Icahn’s modest stake belies his ambition. As the elder statesman of activist investing, the 87-year-old aims to convert small shareholdings into considerable influence. Mr Icahn has nominated three directors to the board of Illumina, whose share price has fallen by 60% since its peak in 2021, in part owing to hubristic dealmaking. On May 25th, after The Economist was published, Mr Icahn’s colourful campaign against the firm’s bosses (16 letters, drawing on Shakespeare and Lincoln) will reach a climax at its annual general meeting. It is one of the

→ Continue reading at The Economist

Similar Articles


Most Popular

Viktor Hovland joins Rory McIlroy, Jon Rahm in PGA Tour lure with unreal playoff win at The Memorial

Viktor Hovland had been knocking on the door lately for his fourth PGA Tour victory. On Sunday, it finally came to fruition as Hovland...

Google's Pixel 7 falls to $499 and also offers a $100 Amazon gift card

Google's Pixel 7 is still one of the best value smartphones available and now you can grab one at the lowest prices we've ever...

Commission: Florida judge should be reprimanded for conduct during Parkland school shooting trial

FORT LAUDERDALE, Fla. (AP) — The Florida judge who oversaw the penalty trial of Parkland school shooter Nikolas Cruz should be publicly reprimanded for...